Tania Jain, MBBS
Hematologist Oncologist, Director, Adult Chimeric Antigen Receptor T cell Therapy Program for Hematological Malignancies, Sidney Kimmel Comprehensive Cancer Center Assistant Professor of Oncology
4 years treating AML
4 years treating AML
Dr. Jain's focus is on the various aspects of cellular therapy in the treatment of hematological malignancies. Her primary research focus is to develop strategies to prevent relapse of hematological malignancies following allogeneic stem cell transplantation.
John Hopkins University School Of Medicine: 1550 Orleans St, Baltimore, MD 21287, USA
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.